المؤلفون: Pinja Ilmarinen (529235), Caroline Stridsman (9035318), Muwada Bashir (10284866), Leena E. Tuomisto (9117274), Iida Vähätalo (8970647), Emma Goksör (10284869), Hannu Kankaanranta (23356), Helena Backman (3499499), Arnulf Langhammer (75692), Päivi Piirilä (600057), Eva Rönmark (764539), Bo Lundbäck (154245), Bright I. Nwaru (8970641), Göran Wennergren (3401258)

مصطلحات موضوعية: Biochemistry, Medicine, Genetics, Pharmacology, Developmental Biology, Science Policy, Environmental Sciences not elsewhere classified, Biological Sciences not elsewhere classified, Asthma, adult-onset asthma, education, socioeconomic status, asthma control, ACT, non-atopic asthma, inhaled corticosteroids, treatment

العلاقة: https://figshare.com/articles/online_resource/Level_of_education_and_asthma_control_in_adult-onset_asthma/14194103Test

الإتاحة: https://doi.org/10.6084/m9.figshare.14194103.v1Test

المؤلفون: Bourdin, Arnaud, Papi, Alberto, Corren, Jonathan, Virchow, J. Christian, Rice, Megan, Deniz, Yamo, Djandji, Michel, Rowe, Paul, Pavord, Ian

المساهمون: Physiologie & médecine expérimentale du Cœur et des Muscles U 1046 (PhyMedExp), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM)-Centre National de la Recherche Scientifique (CNRS), Centre Hospitalier Régional Universitaire Montpellier (CHRU Montpellier), Università degli Studi di Ferrara = University of Ferrara (UniFE), University of California Los Angeles (UCLA), University of California (UC), University of Rostock, Sanofi Cambridge, MA, USA, Regeneron Pharmaceuticals Tarrytown, NY, Sanofi Bridgewater, NJ, USA, University of Oxford

المصدر: ISSN: 0105-4538.

مصطلحات موضوعية: asthma control, exacerbations, inhaled corticosteroids, moderate-to-severe asthma, prebronchodilator FEV1, [SDV.IMM.ALL]Life Sciences [q-bio]/Immunology/Allergology, [SDV.IMM.IMM]Life Sciences [q-bio]/Immunology/Immunotherapy, [SDV.MHEP.PSR]Life Sciences [q-bio]/Human health and pathology/Pulmonology and respiratory tract

العلاقة: hal-02956983; https://hal.science/hal-02956983Test; https://hal.science/hal-02956983/documentTest; https://hal.science/hal-02956983/file/2020%20Bourdin%20et%20al.,%20Dupilumab%20is.pdfTest

الإتاحة: https://doi.org/10.1111/all.14611Test
https://hal.science/hal-02956983Test
https://hal.science/hal-02956983/documentTest
https://hal.science/hal-02956983/file/2020%20Bourdin%20et%20al.,%20Dupilumab%20is.pdfTest

المؤلفون: Buhl, Roland, FitzGerald, J Mark, Meltzer, Eli O, Hoz, Alberto de la, Sigmund, Ralf, Kerstjens, Huib A M, Bleecker, Eugene R

المصدر: Buhl , R , FitzGerald , J M , Meltzer , E O , Hoz , A D L , Sigmund , R , Kerstjens , H A M & Bleecker , E R 2020 , ' Efficacy of once-daily tiotropium Respimat in adults with asthma at GINA Steps 2-5 ' , Pulmonary Pharmacology & Therapeutics , vol. 60 , 101881 . https://doi.org/10.1016/j.pupt.2019.101881Test

مصطلحات موضوعية: Asthma, Tiotropium, Lung function, Asthma control, Disease severity, GINA, IMPROVES LUNG-FUNCTION, INHALED CORTICOSTEROIDS, SYMPTOMATIC ASTHMA, ADD-ON, COMBINATION, SALMETEROL, SAFETY

وصف الملف: application/pdf

العلاقة: https://research.rug.nl/en/publications/f911c2dc-1481-4934-9762-128b805551efTest

الإتاحة: https://doi.org/10.1016/j.pupt.2019.101881Test
https://hdl.handle.net/11370/f911c2dc-1481-4934-9762-128b805551efTest
https://research.rug.nl/en/publications/f911c2dc-1481-4934-9762-128b805551efTest
https://pure.rug.nl/ws/files/110458459/Efficacy_of_once_daily_tiotropium_Respimat_in_adults_with_asthma_at_GINA_Steps_2_5_Elsevier_Enhanced_Reader.pdfTest

المؤلفون: Bingham, Y, Sanghani, N, Cook, J, Hall, P, Jamalzadeh, A, Moore-Crouch, R, Bush, A, Fleming, L, Saglani, S

المساهمون: Asthma UK

المصدر: 2260 ; 2254

مصطلحات موضوعية: Science & Technology, Life Sciences & Biomedicine, Pediatrics, Respiratory System, adherence, atopy, inhaled corticosteroids, monitoring, preschool wheeze, EXHALED NITRIC-OXIDE, ASTHMA CONTROL, KIDS TRACK, CHILDREN, 1114 Paediatrics and Reproductive Medicine

جغرافية الموضوع: United States

العلاقة: Pediatric Pulmonology; http://hdl.handle.net/10044/1/80651Test; AUK-IG-2014-284

الإتاحة: https://doi.org/10.1002/ppul.24943Test
http://hdl.handle.net/10044/1/80651Test

المؤلفون: A. Grosso, F. Locatelli, E. Gini, F. Albicini, C. Tirelli, I. Cerveri, A. G. Corsico

المصدر: Allergy, Asthma & Clinical Immunology, Vol 14, Iss 1, Pp 1-5 (2018)

مصطلحات موضوعية: Asthma control, Pregnancy, Inhaled corticosteroids, Immunologic diseases. Allergy, RC581-607

وصف الملف: electronic resource

العلاقة: http://link.springer.com/article/10.1186/s13223-018-0242-0Test; https://doaj.org/toc/1710-1492Test

الوصول الحر: https://doaj.org/article/5560440e77fc4ae8be3b610dd732c87dTest

المؤلفون: Leshchenko, I. V., Лещенко, И. В.

مصطلحات موضوعية: BRONCHIAL ASTHMA, ASTHMA CONTROL, INHALED CORTICOSTEROIDS, LONG-ACTING Β2-AGONISTS, VILANTEROL, FLUTICASONE FUROATE, ELLIPTA, БРОНХИАЛЬНАЯ АСТМА, КОНТРОЛЬ НАД БРОНХИАЛЬНОЙ АСТМОЙ, ИНГАЛЯЦИОННЫЕ ГЛЮКОКОРТИКОСТЕРОИДЫ, ДЛИТЕЛЬНО ДЕЙСТВУЮЩИЕ Β2-АГОНИСТЫ, ВИЛАНТЕРОЛ, ФЛУТИКАЗОНА ФУРОАТ, ЭЛЛИПТА

وصف الملف: application/pdf

العلاقة: Scopus; Лещенко И.В. Контроль над бронхиальной астмой: актуальная проблема и ее решение в реальной клинической практике. Пульмонология. 2019; 29 (3): 346–352.; http://elib.usma.ru/handle/usma/7262Test

الإتاحة: http://elib.usma.ru/handle/usma/7262Test

المؤلفون: Roche, Nicolas, Campbell, Jonathan D., Krishnan, Jerry A., Brusselle, Guy, Chisholm, Alison, Bjermer, Leif, Thomas, Mike, van Ganse, Eric, van den Berge, Maarten, Christoff, George, Quint, Jennifer, Papadopoulos, Nikolaos G., Price, David

المصدر: Roche , N , Campbell , J D , Krishnan , J A , Brusselle , G , Chisholm , A , Bjermer , L , Thomas , M , van Ganse , E , van den Berge , M , Christoff , G , Quint , J , Papadopoulos , N G & Price , D 2019 , ' Quality standards in respiratory real-life effectiveness research : the REal Life EVidence AssessmeNt Tool (RELEVANT): report from the Respiratory Effectiveness GroupEuropean Academy of Allergy and Clinical Immunology Task Force ' , Clinical and translational allergy , vol. 9 , ....

مصطلحات موضوعية: Asthma, Comparative effectiveness, Quality standards, Observational studies, Database, RETROSPECTIVE DATABASE ANALYSIS, RANDOMIZED CONTROLLED-TRIALS, COPD GUIDELINE DEVELOPMENT, SECONDARY DATA SOURCES, INHALED CORTICOSTEROIDS, ASTHMA CONTROL, COORDINATING EFFORTS, COST-EFFECTIVENESS, PERSISTENT ASTHMA, ADHERENCE

وصف الملف: application/pdf

العلاقة: https://research.rug.nl/en/publications/1a0d1644-0cfa-4faa-89a5-13c0cf07d637Test

الإتاحة: https://doi.org/10.1186/s13601-019-0255-xTest
https://hdl.handle.net/11370/1a0d1644-0cfa-4faa-89a5-13c0cf07d637Test
https://research.rug.nl/en/publications/1a0d1644-0cfa-4faa-89a5-13c0cf07d637Test
https://pure.rug.nl/ws/files/81830157/s13601_019_0255_x.pdfTest

المؤلفون: Valero, A, Olaguibel, J, Delgado, J, Plaza, V, Álvarez, F, Molina, J, Mascarós, E, Quirce, S

مصطلحات موضوعية: Asthma control, Asthma management, Dilemma, Guidelines, Immunotherapy, Inhaled corticosteroids, Paradoxes, Treatment, Adrenal Cortex Hormones, Adrenergic beta-Agonists, Anti-Asthmatic Agents, Asthma, Humans

العلاقة: http://hdl.handle.net/10668/13598Test; http://www.jiaci.org/revistas/vol29issue1_2.pdfTest

الإتاحة: https://doi.org/10.18176/jiaci.0345Test
http://hdl.handle.net/10668/13598Test
http://www.jiaci.org/revistas/vol29issue1_2.pdfTest

المؤلفون: I. V. Leshchenko, И. В. Лещенко

المساهمون: This publication is supported by ZAO “GlaxoSmithKline Traiding”, Russia, according to the current legislation of Russian Federation and Good Publication Practice standards., Статья подготовлена при поддержке компании ЗАО «Глаксо Смит Кляйн Трейдинг» (Россия) в соответствии с действующим законодательством Российской Федерации и принципами Добросовестной практики научных публикаций (Good Publication Practice).

المصدر: PULMONOLOGIYA; Том 29, № 3 (2019); 346-352 ; Пульмонология; Том 29, № 3 (2019); 346-352 ; 2541-9617 ; 0869-0189 ; 10.18093/0869-0189-2019-29-3

مصطلحات موضوعية: Эллипта, asthma control, inhaled corticosteroids, long-acting β2-agonists, vilanterol, fluticasone furoate, Ellipta, контроль над бронхиальной астмой, ингаляционные глюкокортикостероиды, длительно действующие β2-агонисты, вилантерол, флутиказона фуроат

وصف الملف: application/pdf

العلاقة: https://journal.pulmonology.ru/pulm/article/view/1178/928Test; Rabe K.F., Vermeire P.A., Soriano J.B., Maier W.C. Clinical management of asthma in 1999: the Asthma Insights and Reality in Europe (AIRE) study. Eur. Respir. J. 2000; 16 (5): 802–807.; Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention. Updated 2018. Available at: https://ginasthma.org/wp-content/uploads/2018/03/WMSFINAL-GINA-2018-Appendix_v1.3.pdfTest; Partridge M.R., van der Molen T., Myrseth S.E., Busse W.W. Attitudes and actions of asthma patients on regular maintenance therapy: the INSPIRE study. BMC Pulm. Med. 2006; 9: 13. DOI:10.1186/1471-2466-6-13.; Demoly P., Annunziata K., Gubba E., Adamek L. Repeated cross-sectional survey of patient-reported asthma control in Europe in the past 5 years. Eur. Respir. Rev. 2012; 21 (123): 66–74. DOI:10.1183/09059180.00008111.; Iwanaga T., Kumar, M., Goren, A. et al. Cross sectional patient – reported survey on asthma control and associated burdens in Japanese patients with asthma in 2013. Ther. Res. 2015; 36 (3): 235–246.; FitzGerald J.M., Boulet L.P., McIvor R.A. et al. Asthma control in Canada remains suboptimal: the Reality of Asthma Control (TRAC) study. Can. Respir. J. 2006; 13 (5): 253–259. DOI:10.1155/2006/753083.; Mintz M., Gilsenan A.W., Bui C.L. et al. Assessment of asthma control in primary care. Curr. Med. Res. Opin. 2009; 25 (10): 2523–2531. DOI:10.1185/03007990903218655.; Price D., Fletcher M., van der Molen T. Asthma control and management in 8,000 European patients: the REcognise Asthma and LInk to Symptoms and Experience (REALISE) survey. NPJ Prim. Care. Respir. Med. 2014; 24: 14009. DOI:10.1038/npjpcrm.2014.9.; Архипов В.В., Григорьева Е.В., Гавришина Е.В. Контроль над бронхиальной астмой в России: результаты многоцентрового наблюдательного исследования НИКА. Пульмонология. 2011; (6): 87–93. DOI:10.18093/0869-0189-2011-0-6-87-93.; Haughney J., Price D., Kaplan A. et al Achieving asthma control in practice: anderstanding the reasons of poor control. Respir. Med. 2008; 102 (12): 1681–1693. DOI:10.1016/j.rmed.2008.08.003.; Nose M., Barbui C., Gray R., Tansella M. Clinical interventions for treatment non-adherence in psychosis: meta-analysis. Br. J. Psychiatry. 2003; 183 (3):197–206. DOI:10.1192/bjp.183. 3.197.; Petrie K.J., Perry K., Broadbent E., Weinman J. A text message programme designed to modify patients' illness and treatment beliefs improves self-reported adherence to asthma preventer medication. Br. J. Health Psychol. 2012; 17 (1): 74–84. DOI:10.1111/j.2044-8287.2011.02033.x.; Grant A.C., Walker R., Hamilton M., Garrill K. The ELLIPTA® dry powder inhaler: design, functionality, in vitro dosing performance and critical task compliance by patients and caregivers. J. Aerosol Med. Pulm. Drug Deliv. 2015; 28 (6): 474–485. DOI:10.1089/jamp.2015.1223.; Asthma Control Test. Available at: http://www.asthma.com/additional-resources/asthma-control-test.htmlTest; Thomas M., Kay S., Pike J. et al. The Asthma Control Test (ACT) as a predictor of GINA guideline-defined asthma control: analysis of a multinational cross-sectional survey. Prim. Care Respir. J. 2009; 18 (1): 41–49. DOI:10.4104/pcrj.2009. 00010.; O’Byrne P.M., Reddel H.K., Eriksson G. et al. Measuring asthma control: a comparison of three classification systems. Eur. Respir. J. 2010; 36 (2): 269–276. DOI:10.1183/09031936.00124009.; Ko F.W., Hui D.S., Leung T.F. et al. Evaluation of the asthma control test: a reliable determinant of disease stability and a predictor of future exacerbations. Respirology. 2012; 17 (2): 370– 378. DOI:10.1111/j.1440-1843.2011.02105.x.; Valotis A., Högger P. Human receptor kinetics and lung tissue retention of the enhanced-affinity glucocorticoid fluticasone furoate. Respir. Res. 2007; 8: 54–62. DOI:10.1186/1465-9921-8-54.; Slack R.J., Barrett V.J. Morrison V.S. et al. In vitro pharmacological characterization of vilanterol, a novel long-acting β2-adrenoceptor agonist with 24-hour duration of action. J. Pharmacol. Exp. Ther. 2013; 344 (1): 218–230. DOI:10.1124/ jpet.112.198481.; New J.P., Bakerly N.D., Leather D., Woodcock A. Obtaining real-world evidence: the Salford Lung Study. Thorax. 2014; 69 (12): 1152–1154. DOI:10.1136/thoraxjnl-2014-205259.; Vestbo J., Leather D., Bakerly N.D. et al. Effectiveness of fluticasone furoate–vilanterol for COPD in clinical practice. N. Engl. J. Med. 2016; 375 (13): 1253–1260. DOI:10.1056/NEJMoa1608033.; Woodcock A., Vestbo J., Bakerly N.D. et al. Effectiveness of fluticasone furoate plus vilanterol on asthma control in clinical practice: an open label, parallel group, and randomized controlled trial. Lancet. 2017; 390 (10109): 2247–2255. DOI: 10. 1016/S0140-6736(17)32397-8.; Schatz M., Sorkness C.A., Li J.T. et al. Asthma Control Test: reliability, validity, and responsiveness in patients not previously followed by asthma specialists. J. Allergy Clin. Immunol. 2006; 117 (3): 549–556. DOI:10.1016/j.jaci.2006.01.011.; Svedsater H., Jones R., Bosanquet N. et al. Patient-reported outcomes with initiation of fluticasone furoate/vilanterol versus continuing usual care in the Asthma Salford Lung Study. Respir. Med. 2018; 141: 198–206. DOI: DOI:10.1016/j.rmed.2018.06.003.; Marks G.B., Dunn S.M., Woolcock A.J. An evaluation of an asthma quality of life questionnaire as a measure of change in adults with asthma. J. Clin. Epidemiol. 1993; 46 (10): 1103–1111.; Juniper E.F., Buist A.S., Cox F.M. et al. Validation of a standardized version of the Asthma Quality of Life Questionnaire. Chest. 1999; 115 (5): 1265–1270. DOI:10.1378/chest.115.5.1265.; Reilly M.C., Zbrozek A.S., Dukes E.M. The validity and reproducibility of a work productivity and activity impairment instrument. PharmacoEconomics. 1993; 4 (5): 353– 365. DOI:10.2165/00019053-199304050-00006.; EQ-5D® Is a Standardized Instrument for as a Measure of Health Outcome. EQ-5D Instrument. EuroQol 5-Dimensions 3-Levels Questionnaire, EQ-5D-3L. Avail able at: https://euroqol.orgTest/; Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention. Updated 2019. Available at: http://www.ginasthma.orgTest/; https://journal.pulmonology.ru/pulm/article/view/1178Test

الإتاحة: https://doi.org/10.18093/0869-0189-2019-29-3-346-352Test
https://doi.org/10.18093/0869-0189-2019-29-3Test
https://doi.org/10.1186/1471-2466-6-13Test
https://doi.org/10.1183/09059180.00008111Test
https://doi.org/10.1155/2006/753083Test
https://doi.org/10.1185/03007990903218655Test
https://doi.org/10.1038/npjpcrm.2014.9Test
https://doi.org/10.18093/0869-0189-2011-0-6-87-93Test
https://doi.org/10.1016/j.rmed.2008.08.003Test
https://doi.org/10.1192/bjp.183Test

المؤلفون: Ashley Woodcock, Alexander Wilkinson

المصدر: British Journal of Clinical Pharmacology. 88:3016-3022

مصطلحات موضوعية: Pharmacology, medicine.medical_specialty, business.industry, Inhaler, Dry Powder Inhalers, Inhaled corticosteroids, Environment, medicine.disease, Asthma, Greenhouse Gases, Greenhouse gas, Asthma control, Administration, Inhalation, Carbon footprint, medicine, Salbutamol, Humans, Albuterol, Pharmacology (medical), Environmental impact assessment, Metered Dose Inhalers, Intensive care medicine, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8833db435c301ca255364c8a63e1b2aaTest
https://doi.org/10.1111/bcp.15135Test